These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1333998)

  • 1. Comparison of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin, with or without dihydroergotamine, in abdominal hysterectomy.
    Kaaja R; Lehtovirta P; Venesmaa P; Kajanoja P; Halonen P; Gummerus M; Partanen S
    Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):141-5. PubMed ID: 1333998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV; Stringer MD; Hedges AR; Parker CJ; Welzel D; Ward VP; Sanderson RM; Cooper D; Kakkar S
    Am J Surg; 1989 Apr; 157(4):413-8. PubMed ID: 2539025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of low molecular weight heparin-DHE and conventional heparin-DHE (with acenocoumarol) in patients undergoing gynaecological surgery.
    Steiner RA; Keller K; Lüscher T; Schreiner WE
    Arch Gynecol Obstet; 1989; 244(3):141-50. PubMed ID: 2544152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].
    Weber U; Koppenhagen K; Mälzer H; Matthes M
    Langenbecks Arch Chir; 1991; 376(3):147-51. PubMed ID: 1651434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A; Vochelle N; Mazas F; Mansat C; Zucman J; Landais A; Pascariello JC; Weill D; Butel J
    Thromb Haemost; 1988 Dec; 60(3):407-10. PubMed ID: 2853459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis.
    Sasahara AA; Koppenhagen K; Häring R; Welzel D; Wolf H
    Br J Surg; 1986 Sep; 73(9):697-700. PubMed ID: 3530367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF; Bachmann F; Hoek J; Büller HR; Postel M; Samama M; Vandenbroek MD
    BMJ; 1991 Sep; 303(6802):543-8. PubMed ID: 1655136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of post-operative thromboembolism in general surgery with enoxaparin: preliminary findings.
    Haas S; Flosbach CW
    Acta Chir Scand Suppl; 1990; 556():96-102. PubMed ID: 1963023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness and side effects of low-molecular weight heparin-dihydroergotamine in preventing thromboembolism in abdominal surgery].
    Voigt J; Hamelmann H; Hedderich J; Seifert J; Buchhammer T; Köhler A
    Zentralbl Chir; 1986; 111(21):1269-305. PubMed ID: 3544605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
    Merli G; Spiro TE; Olsson CG; Abildgaard U; Davidson BL; Eldor A; Elias D; Grigg A; Musset D; Rodgers GM; Trowbridge AA; Yusen RD; Zawilska K;
    Ann Intern Med; 2001 Feb; 134(3):191-202. PubMed ID: 11177331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of thromboembolic complications with miniheparin-dihydroergotamine in patients undergoing lumbar disc operations.
    Gruber UF; Rem J; Meisner C; Gratzl O
    Eur Arch Psychiatry Neurol Sci; 1984; 234(3):157-61. PubMed ID: 6386481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Leclerc J; Powers PJ; Jay RM; Neemeh J
    Ann Intern Med; 1991 Apr; 114(7):545-51. PubMed ID: 1848054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of postoperative thromboembolisms in general surgery by the combination of heparin and dihydroergotamine.
    Sándor T; László E; Magyary F; Turcsányi G; Hetényi L; Izinger E
    Acta Chir Hung; 1986; 27(2):107-14. PubMed ID: 3529772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery.
    Lassen MR; Borris LC; Christiansen HM; Møller-Larsen F; Knudsen VE; Boris P; Nehen AM; de Carvalho A; Jurik AG; Nielsen BW
    Br J Surg; 1988 Jul; 75(7):686-9. PubMed ID: 2843255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
    Hoffman R; Largiadèr F; Brütsch HP
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1179-84. PubMed ID: 1983509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of thromboembolic disease in general surgery with enoxaparin (Clexane).
    Samama M; Combe S
    Acta Chir Scand Suppl; 1990; 556():91-5. PubMed ID: 1963022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.